Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Potential Outcomes at 76 patients - wow !

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Nov 14, 2023 2:49pm

191 Views

Post# 35735084

RE:RE:RE:Potential Outcomes at 76 patients - wow !

Yes the backwardization by Paradigm over the past couple of years is curious

Totally agree that dilution is likely more than offset by probability of success improvements.*

Only thing I can think of is that Analysts like to be conservative, and when the SP starts moving they tend to start bumping up the targets to more realistic levels.

MM

* of course the other way that investors can counter dilution is to buy cheap shares (under $ 1) if you think its going to $ 1.60, $ 2, $ 4 etc.

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features